STOCK TITAN

Glass House Brands to Host Third Quarter 2024 Conference Call on November 13, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Glass House Brands, a leading vertically-integrated cannabis company in the U.S., has announced its upcoming third quarter 2024 financial results release scheduled for November 13, 2024, after market close. The company will host a conference call at 5:00 p.m. Eastern Time to discuss the results. Investors can access the live webcast and replay through the company's website or by dialing 1.888.596.4144 with Conference ID 7699737#.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-4.63% News Effect

On the day this news was published, GLASF declined 4.63%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

LONG BEACH, Calif. and TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company” (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., today announced that it will report financial results for the third quarter ended September 30, 2024, on Wednesday, November 13, 2024, after market close. The Company will host a conference call to discuss the results at 5:00 p.m. Eastern Time.

Participants can find the live webcast and replay here or on the Glass House Brands website at https://glasshousebrands.com/news-events/events-and-webcasts/. The webcast will be archived for approximately 30 days.

Participants interested in dialing in can call 1.888.596.4144 and type in the Conference ID 7699737# when the line is picked up. A replay of the call will be available here. We also post all historical earnings call webcast audio files, call transcripts, financial statements, and management discussion and analyses here.

About Glass House Brands

Glass House is one of the fastest-growing, vertically integrated cannabis companies in the U.S., with a dedicated focus on the California market and building leading, lasting brands to serve consumers across all segments. From its greenhouse cultivation operations to its manufacturing practices, from brand-building to retailing, the company's efforts are rooted in the respect for people, the environment, and the community that co-founders Kyle Kazan, Chairman and CEO, and Graham Farrar, Board Member and President, instilled at the outset. Whether it be through its portfolio of brands, which includes Glass House FarmsPLUS ProductsAllswell and Mama Sue Wellness or its network of retail dispensaries throughout the state of California, which includes The Farmacy, Natural Healing Center and The Pottery, Glass House is committed to realizing its vision of excellence: outstanding cannabis products, produced sustainably, for the benefit of all. For more information and company updates, visit www.glasshousebrands.com/ and https://ir.glasshousebrands.com/contact/email-alerts/.

For further information, please contact:
Glass House Brands Inc.
John Brebeck, Vice President of Investor Relations 
T: (562) 264-5078 
E: ir@glasshousebrands.com

Mark Vendetti, Chief Financial Officer 
T: (562) 264-5078 
E: ir@glasshousebrands.com

Investor Relations Contact:
KCSA Strategic Communications
Phil Carlson
T: 212-896-1233
E: GlassHouse@kcsa.com


FAQ

When will Glass House Brands (GLASF) release Q3 2024 earnings?

Glass House Brands will release its third quarter 2024 financial results on Wednesday, November 13, 2024, after market close.

How can I join Glass House Brands (GLASF) Q3 2024 earnings call?

You can join by accessing the live webcast on Glass House Brands' website or by dialing 1.888.596.4144 with Conference ID 7699737#.

What time is Glass House Brands (GLASF) Q3 2024 earnings call?

The earnings conference call is scheduled for 5:00 p.m. Eastern Time on November 13, 2024.
Glass House Brands Inc

OTC:GLASF

GLASF Rankings

GLASF Latest News

GLASF Latest SEC Filings

GLASF Stock Data

592.76M
54.87M
9.59%
6.98%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Long Beach